Heart failure, also known as congestive cardiac failure, is a heterogeneous condition where the heart is unable to pump a sufficient volume of blood around the body to meet the metabolic needs of the body. Heart failure commonly occurs in those over 50, and the severity of the condition increases with age. The symptoms of heart failure can develop in two ways. They develop quickly in acute heart failure (AHF), and slowly in chronic heart failure (CHF). Those who have AHF can be quickly hospitalized due to the severity of symptoms.
The US will see the highest AGR of heart failure of 2.91% between 2018 and 2028
GlobalData’s Heart Failure: Epidemiology Forecast to 2028 explores a forecast for diagnosed incident cases of heart failure and diagnosed prevalent cases of CHF in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China). This data is used to predict estimated AHF hospitalizations and diagnosed prevalent cases of heart failure severity accordingly to NYHA functional classification and AHA staging system.
Diagnosed incident cases of heart failure will rise from 2,974,022 in 2018 to 3,638,957 in 2028. The US will see the highest AGR at 2.91% and Germany will see the lowest AGR of 1.25%.
Key highlights of this report include:
- Heart failure epidemiology report and models providing an overview of risk factors and global trends in the 8MM.
- 10-year forecast for diagnosed incident cases of HF and diagnosed prevalent cases of CHF by age, sex, and ejection fraction
- Exploration of AHF hospitalizations and prevalent cases
- A rundown of disease trends over a 10-year forecast period
Develop business strategies by understanding trends in the market. Quantify patient populations in the global heart failure market and use this to create better product plans. Understand the impact of this disease on people and use the information to make better investment decisions.
GlobalData is this website’s parent business intelligence company.